Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck CEO: Using Keytruda Could Extend Patient's Life By 13 Months On Average
Merck CEO: Using Keytruda Could Extend Patient's Life By 13 Months On Average
Merck CEO: Using Keytruda Could Extend Patient's Life By 13 Months On Average
Submitted by
admin
on December 22, 2015 - 10:37am
Source:
Yahoo/Benzinga
News Tags:
Merck
Kenneth Frazier
Keytruda
lung cancer
Headline:
Merck CEO: Using Keytruda Could Extend Patient's Life By 13 Months On Average
Do Not Allow Advertisers to Use My Personal information
